These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14156840)

  • 1. [COMPARATIVE EVALUATION OF THE SUBJECTIVE EFFECTS OF DEXTROAMPHETAMINE, METHYLPHENIDATE AND PLACEBO].
    TETREAULT L
    Can Med Assoc J; 1964 Jul; 91(2):61-6. PubMed ID: 14156840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSYCHOPHARMACOLOGY OF CHLORPHENTERMINE AND D-AMPHETAMINE. A COMPARATIVE STUDY OF THEIR EFFECTS IN NORMAL MALES.
    DIMASCIO A; BUIE DH
    Clin Pharmacol Ther; 1964; 5():174-84. PubMed ID: 14155159
    [No Abstract]   [Full Text] [Related]  

  • 3. A PHARMACOLOGY TEACHING EXERCISE IN DRUG EVALUATION: A COMPARISON OF THE DIURETIC EFFICACY OF CLOREXOLONE, HYDROCHLOROTHIAZIDE AND A PLACEBO IN NORMAL SUBJECTS.
    BLOOMFIELD SS; TETREAULT L
    Can Med Assoc J; 1965 Mar; 92(13):662-5. PubMed ID: 14269436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALPHA-BENZYLTETRAHYDROFURFURYLAMINES--A NEW SERIES OF PSYCHOMOTOR STIMULANTS. III. THE PHARMACOLOGY OF D-THREO ALPHA-BENZYL-N-ETHYLTETRAHYDROFURFURYLAMINE (ZYLOFURAMINE).
    HARRIS LS; CLARKE RL; DEMBINSKI JR
    Arch Int Pharmacodyn Ther; 1963 Dec; 146():392-405. PubMed ID: 14099588
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial.
    Wagner GJ; Rabkin R
    J Clin Psychiatry; 2000 Jun; 61(6):436-40. PubMed ID: 10901342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
    Herrmann N; Rothenburg LS; Black SE; Ryan M; Liu BA; Busto UE; Lanctôt KL
    J Clin Psychopharmacol; 2008 Jun; 28(3):296-301. PubMed ID: 18480686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the abuse potential of modafinil using methylphenidate as a reference.
    Jasinski DR
    J Psychopharmacol; 2000 Mar; 14(1):53-60. PubMed ID: 10757254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CHANGES INDUCED BY SOME PSYCHOPHARMACOLOGICAL AGENTS IN CIRCULATORY AND NEUROPSYCHIC CONDITIONS DUE TO ENVIRONMENTAL HYPER-PRESSURE].
    ALBANO G; DIBENEDETTO A; CRISCUOLI PM; INDOVINA T; CANDIA A; CIULLA C
    Boll Soc Ital Biol Sper; 1963 Dec; 39():2082-5. PubMed ID: 14156765
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
    Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
    J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo.
    Schwartz G; Amor LB; Grizenko N; Lageix P; Baron C; Boivin DB; Joober R
    J Am Acad Child Adolesc Psychiatry; 2004 Oct; 43(10):1276-82. PubMed ID: 15381895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of chlorpromazine, dextroamphetamine and methylphenidate on the behaviour and intellectual functioning of hyperactive children.
    Weiss G; Minde K; Douglas V; Werry J; Sykes D
    Can Med Assoc J; 1971 Jan; 104(1):20-5. PubMed ID: 5540117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METHYSERGIDE INDUCED DEGRANULATION OF THE BASOPHIL LEUKOCYTE IN MAN.
    SHELLEY WB; RESNIK SS
    J Invest Dermatol; 1964 Dec; 43():491-8. PubMed ID: 14234855
    [No Abstract]   [Full Text] [Related]  

  • 14. MODIFIED METHOD FOR STUDYING ANOREXIGENIC AGENTS IN DOGS.
    ADAMS HJ; GREENE LC
    J Pharm Sci; 1964 Nov; 53():1405-6. PubMed ID: 14253606
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
    Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM
    J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.
    Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM
    J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the subjective effects of stimulants in casual users. A methodology and preliminary results.
    Cole JO; Pope HG; LaBrie R; Ionescu-Pioggia M
    Clin Pharmacol Ther; 1978 Aug; 24(2):243-52. PubMed ID: 28194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate does not improve cognitive function in healthy sleep-deprived young adults.
    Bray CL; Cahill KS; Oshier JT; Peden CS; Theriaque DW; Flotte TR; Stacpoole PW
    J Investig Med; 2004 Apr; 52(3):192-201. PubMed ID: 15222409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.